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Getting Good Vibes
The Therapeutic Power of Microbubbles and Ultrasound*
Flordeliza S. Villanueva, MD
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TMicrobubbles are microspheres containing a
shell-encapsulated gas, which are used as intra-
vascular ultrasound contrast agents in diagnostic
echocardiography (1). Although microbubbles
may vary in their shell composition, all expand
and contract (vibrate) when exposed to specific
frequencies of ultrasound at appropriate acoustic
pressures (2). Increasingly, bioeffects caused by
ultrasound-induced microbubble vibration in vivo
have been harnessed for therapeutic gain.
See page 1253
Ultrasound-induced microbubble vibrations en-
hance gene delivery and thrombolysis (“sonothrom-
bolysis”), and transiently open the normally imper-
vious blood-brain barrier in pre-clinical models
(3–5). In the realm of gene delivery, ultrasound-
targeted microbubble vibrations that culminate in
microbubble destruction hold the promise of a
noninvasive, nonimmunogenic, nonviral means of
delivering genes to a target via simple intravenous
injection. This approach offers an ideal “theranostic
tool,” using navigation of the ultrasound beam to
destroy the microbubbles only at the site where
genes should be delivered (thus achieving targeting)
while ultrasonically imaging the target to confirm
microbubble delivery and destruction.
Shohet et al. (6) were the first to report that
transthoracic ultrasound during intravenous deliv-
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ene resulted in higher rat myocardial beta-
alactosidase expression compared with controls.
his group subsequently published studies describ-
ng effects of ultrasound-targeted destruction of
icrobubbles carrying therapeutic genes on pancre-
tic beta cell regeneration and function (7). Others
ave subsequently reported therapeutic gene deliv-
ry using ultrasound-targeted microbubble destruc-
ion (UTMD) to promote angiogenesis in limb
schemia (8). We recently reported growth inhibi-
ion of murine squamous cell carcinomas after
ntravenous delivery of lipid microbubbles bearing
he thymidine kinase suicide gene, in the presence
f ganciclovir and ultrasound (9). Such studies have
emonstrated that this method critically requires
he dual presence of ultrasound (i.e., gene-loaded
icrobubbles are not sufficient) and microbubbles
i.e., ultrasound and naked plasmids are not suffi-
ient). Nonetheless, the other requirements for
ene delivery via UTMD with respect to what
arameters optimize efficacy are largely unknown,
eflecting our incomplete understanding of the
echanisms underlying UTMD.
What, in fact, are the “active ingredients” that
ediate the gene therapeutic effects of UTMD?
ome of what we do know: microbubble acoustic
ehavior ranges from “stable cavitation,” where the
icrobubble vibrates at harmonic multiples of the
ransmitted ultrasound frequency, to “inertial cavi-
ation,” whereby the microbubble vibrates asymmetri-
ally and violently erupts (2,10). Such microbubble
ehaviors occurring in proximity to cells cause tran-
ient, self-sealing nanoscale pores to form in cell
embranes (sonoporation), endocytosis, and en-
ancement of endothelial layer permeability (11–13).
hese mechanisms could promote drug or nucleic
cid uptake by the cell. Unlike other nucleic acid
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1264carriers that rely on endocytosis for cell internaliza-
tion, sonoporation facilitates nonendosomal uptake
of macromolecules, which could spare macromole-
cules from a potential endosomal “dead-end” fate.
Major mechanisms for UMTD may be a combina-
tion of hydrodynamic sequelae of microbubble os-
cillation/disruption on cell membranes (microjet-
ting and/or microstreaming) (10); direct mechanical
effects of a vibrating microbubble alternately
stretching and invaginating a cell membrane (11);
and induction of calcium influx and subsequent
increases in endothelial permeability (14). It should
be noted that the putative mechanisms men-
tioned here derive from observations made largely
in vitro and under ultrasound conditions with low
to modest acoustic pressures (1 MPa). Thus,
the relevance of these mechanisms to the in vivo
models that have shown successful gene therapy,
in which high acoustic pressures have been used,
is unclear.
What exactly happens between ultrasound, mi-
crobubbles, and the microvessel wall that facili-
tates gene transduction? Do the key events reside
in the capillaries, the arterioles, or the venules?
Imaging studies of microbubble–microvessel wall
interactions have yielded some insight. Using
intravital microscopy, Price et al. (15) demon-
strated that ultrasound-induced ruptures of mi-
crobubbles transiting the capillaries of exterior-
ized rat spinotrapezious muscle caused capillary
ruptures that dispersed 205- to 503-nm colloidal
particles into a tissue area of about 25  103m.
It was estimated that the extent of microvascular
disruption could be as little as 1.5% of all capil-
laries to achieve particle coverage of 50% of total
muscle area, suggesting that relatively few capil-
lary ruptures could distribute macromolecules
across a significant area of tissue. Intravital mi-
croscopy of mouse cremaster muscle during de-
livery of fluorescent plasmid DNA–loaded micro-
bubbles in the presence of high-pressure
ultrasound demonstrated perivascular deposition
of DNA, with only 10% to 15% of depositions
associated with visible microvascular hemorrhage,
suggesting that gross hemorrhage was not an
absolute prerequisite for extravascular penetration
of plasmid DNA (16). More recently, high-speed
imaging of rat cremaster muscle showed micro-
vascular deformations caused by intravascular mi-
crobubbles vibrating in response to ultrasound,
with microvessel distention and invagination, and
liquid jets directed away from the near vessel wall
(17). One can only speculate, but also graphically simagine, what such perturbations on the endo-
thelial surface of microvessels might do to indi-
vidual endothelial cell membrane permeability,
vascular endothelial lining permeability, other
endothelial functions, or even cytoplasmic or
nuclear trafficking of genes.
In this issue of iJACC, Xie et al. (18) add yet
another observation regarding UTMD that adds
both additional information as well as mystery to
the question of how vibrating microbubbles facili-
tate gene transfer. The study investigated whether
microbubble targeting to an endothelial epitope
would increase UTMD-mediated gene transduc-
tion. Lipid microbubbles bearing an antibody
against the leukocyte adhesion molecules
P-selectin or intercellular adhesion molecule-1
(ICAM-1) were charge coupled to plasmid DNA
encoding for the luciferase reporter. A battery of
in vitro flow chamber studies, intravital micros-
copy of activated murine cremaster muscle, and in
vivo imaging studies of ischemic murine
hindlimb confirmed that the plasmid-loaded tar-
geted microbubbles adhered to inflamed tissue.
P-selectin–targeted microbubbles carrying the lu-
ciferase gene were intravenously delivered to mice
after hindlimb ischemia-reperfusion, during si-
multaneous ultrasound delivery, with 3 different
acoustic pressures tested in separate groups. Us-
ing bioluminescence imaging and real-time poly-
merase chain reaction (PCR) for luciferase
mRNA as readouts, it was found that compared
with nontargeted microbubbles, P-selectin–
targeted microbubbles resulted in higher lucifer-
ase expression only at the lower acoustic pressures
0.6 MPa). At the higher acoustic pressures (1.0
nd 1.8 MPa), targeting did not confer additional
ene transduction.
Although the authors did not report a statistical
omparison of transduction between the experi-
ental groups as a function of acoustic pressure, the
ata in Figure 4 suggest that high acoustic pressure
rumps all: although P-selectin targeting enhanced
ransduction at the lower acoustic pressure of 0.6
Pa, the extent of transduction was still lower than
hat achieved with targeted- or nontargeted micro-
ubbles at the higher acoustic pressures. Further,
hereas the authors suggest that the lower acoustic
ressures combined with microbubble targeting
ould be preferable to the high acoustic pressures
ue to lesser microvascular hemorrhage (albeit at
he cost of less transduction), it was interesting that
here were no differences among the acoustic pres-
ure groups with respect to long-term histological
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1265fibrosis or vascular permeabilization. Thus, if the
goal is to achieve maximal gene transduction while
avoiding significant long-term toxicity, one cannot
definitively conclude from this study whether lower
acoustic pressure  microbubble targeting or high
acoustic pressure (without targeting) is the pre-
ferred approach.
But ignoring for a moment the superior trans-
duction results at high pressures, the more interest-
ing question posed by this study is why did
P-selectin targeting improve transduction at the
lower acoustic pressure? P-selectin expression post-
ischemia occurs predominantly in the venules,
which present less endothelial surface area com-
pared with the capillaries. Moreover, molecular
imaging studies have shown that relatively few
targeted bubbles actually adhere to the target rela-
tive to the number of targeted microbubbles in-
jected (19). How is it, then, that the presumably few
microbubbles adhering to the venular endothelium
could have mediated a 5-fold increase in gene
transduction? What is the in vivo microvascular
acoustic behavior of a microbubble at the 0.6-MPa
(1.6-MHz) ultrasound that was delivered, which
likely lies somewhere between stable and inertial
cavitation regimes? Are the adhered microbubbles
bursting? The in vitro cavitation data presented by
the authors indicate that 0.5-MPa 1-MHz ultra-
sound destroys freely floating lipid microbubbles by
the eighth pulse train. However, an adhered micro-
bubble that is spatially confined in a tiny venulecombined with glycoprotein IIb/IIIa
targeted microbubbles improves mi- using ultrasoundlate when insonified at 0.6 MPa and potentially
create the conditions that have been associated with
increased individual cell membrane permeability,
enhanced endocytosis, and “loosening” of junctions
between endothelial cells (4,11–13). Also, whether
plasmid availability at the target site requires mi-
crobubble breakage and/or “liberation” from the
lipid shell is unknown. The fact that transduction is
greater at higher acoustic pressures might suggest
that microbubble breakage is required to ensure
plasmid availability.
Whatever the “active ingredient(s)” within a
given treatment strategy, microbubble targeting is
important and incremental, but the effects of tar-
geting do not appear to supersede the permissive
effects on gene transduction that are conferred by
acoustic conditions associated with inertial cavita-
tion. The observations reported by Xie et al. (18)
add to our awareness of the principles (e.g., target-
ing) that may help guide development of gene
therapy protocols using microbubbles and ultra-
sound. Importantly, this study also underscores the
need to gain mechanistic insight in order to ratio-
nally optimize gene theranostic approaches utilizing
ultrasound-mediated microbubble destruction.
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